Boothbay Fund Management, LLC Biovie Inc. Transaction History

Boothbay Fund Management, LLC

  • $4.17 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$2.75 - $5.17 $24,169 - $45,439
8,789 Added 9.58%
100,518 $342,000
Q2 2023

Aug 14, 2023
BUY
$4.09 - $8.29 $70,650 - $143,201
17,274 Added 23.2%
91,729 $395,000
Q1 2023

May 15, 2023
BUY
$4.89 - $10.53 $308,431 - $664,169
63,074 Added 554.2%
74,455 $601,000
Q4 2022

Feb 14, 2023
BUY
$3.86 - $13.38 $43,930 - $152,277
11,381 New
11,381 $88,000

Others Institutions Holding BIVI

# of Institutions
57
Shares Held
7M
Call Options Held
51.7K
Put Options Held
353K
View Full List

About BIOVIE INC.

BIVI Quotes by TradingView
  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $12.1M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email